| Natera, Inc. Common Stock | $38.7b | $263.51 | -0.2% | 942.7K | |
| Illumina Inc | $31.0b | $203.26 | -1.5% | 2.0M | |
| Labcorp Holdings Inc. | $25.0b | $314.02 | +0.5% | 371.7K | |
| QIAGEN N.V. | $8.7b | $39.92 | -3.9% | 1.7M | |
| BillionToOne, Inc. Class A Common Stock | $6.4b | $108.63 | +5.4% | 742.8K | |
| 10x Genomics, Inc. Class A Common Stock | $6.0b | $47.52 | -0.8% | 1.9M | |
| Veracyte, Inc. | $3.6b | $46.08 | -0.7% | 918.2K | |
| CareDx, Inc. | $2.3b | $46.50 | -3.4% | 925.4K | |
| NeoGenomics, Inc. | $2.0b | $15.72 | -3.5% | 1.5M | |
| GeneDx Holdings Corp. Class A Common Stock | $2.0b | $69.53 | -1.3% | 767.5K | |
| Personalis, Inc. Common Stock | $1.4b | $13.51 | -0.1% | 1.3M | |
| Azenta, Inc. | $1.3b | $31.80 | +5.7% | 960.8K | |
| Opko Health Inc. | $1.0b | $1.35 | +3.8% | 2.3M | |
| Mesa Laboratories Inc | $0.6b | $102.78 | +1.8% | 93.0K | |
| Fulgent Genetics, Inc. Common Stock | $470.0m | $18.52 | -0.1% | 332.8K | |
| Pacific Biosciences of California, Inc. | $441.1m | $1.28 | -10.1% | 10.7M | |
| Prenetics Global Limited Class A Ordinary Share | $314.8m | $18.45 | -1.7% | 86.9K | |
| Myriad Genetics Inc | $288.9m | $3.21 | -0.5% | 3.3M | |
| Insight Molecular Diagnostics Inc. Common Stock | $150.1m | $5.01 | -2.5% | 102.8K | |
| ALPS Group Inc Ordinary Share | $68.3m | $0.40 | 0.0% | 7.3K | |
| Quantum Cyber N.V. Ordinary Shares | $28.7m | $1.45 | -3.3% | 930.8K | |
| Bionano Genomics, Inc. Common Stock | $12.3m | $1.10 | -4.0% | 75.6K | |
| BioNexus Gene Lab Corp Common stock | $3.2m | $1.55 | 0.0% | 3.5K |